Work

Identification of RIOK2 as a master regulator of human blood cell development

Year: 2021

Type: article

Source: Nature Immunology

DOI: 10.1038/s41590-021-01079-w

Authors: Shrestha Ghosh, Mahesh Raundhal, Samuel A. Myers, Steven A. Carr, Xi Chen, Gregory A. Petsko, Laurie H. Glimcher

Institutions: Harvard University, Dana-Farber Cancer Institute, Jnana Therapeutics (United States), Broad Institute, La Jolla Institute for Immunology, Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center, Brigham and Women's Hospital, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Dana-Farber Cancer Institute, Pussycat Foundation, Health Services Research Programme, National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: G1836300776, Multi-faceted Roles of an Atypical Kinase RIOK2 in Erythropoiesis and Myelodyplastic Syndromes, Center of Excellence for High Throughput Proteogenomic Characterization, G6382017357, MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS

OpenAlex ID: W4200445924

FWCI: 2.492

Cites: 51

Cited by: 24

Related to: 10